QL
NBIX icon

Quarry LP’s Neurocrine Biosciences NBIX Stock Holding History

Quarry LP’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,700
Closed -$339K – 2389
2025
Q2 		$339K Buy
2,700
+2,200
+440% +$252K 0.07% 248
2025
Q1 		$55.3K Sell
500
-1,200
-71% -$152K 0.01% 751
2024
Q4 		$232K Sell
1,700
-800
-32% -$98.9K 0.03% 221
2024
Q3 		$288K Buy
2,500
+2,478
+11,264% +$340K 0.07% 188
2024
Q2 		$3.03K Buy
+22
New +$3.02K ﹤0.01% 1582
2024
Q1 		– Sell
-300
Closed -$39.5K – 1825
2023
Q4 		$39.5K Sell
300
-1,598
-84% -$184K 0.01% 413
2023
Q3 		$214K Buy
+1,898
New +$200K 0.05% 141

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quarry LP's NBIX Position: Q3 2025 in Review

Quarry LP sold out of Neurocrine Biosciences (NBIX) in Q3 2025, closing a stake of 2,700 shares — an estimated $339K sold.

Quarry LP first reported a position in NBIX in Q3 2023 and held it in 7 quarters. The position peaked at $339K in Q2 2025. 649 funds tracked by Wall St. Rank hold NBIX as of Q3 2025.

  • Quarry LP reported no remaining Neurocrine Biosciences position as of Q3 2025 after selling out during the quarter.
  • Quarry LP sold 2,700 Neurocrine Biosciences shares in Q3 2025, an estimated $339K.
  • Quarry LP first reported a position in Neurocrine Biosciences in Q3 2023 and held it in 7 quarters.
  • Quarry LP's Neurocrine Biosciences position peaked at $339K in Q2 2025.
  • 649 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2025.

Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.